The artificial pancreas is a dream that is slowly coming true. In a new Insulin Nation article, author Martin Hensel reviews where we are and where we might be going with automated insulin dosing. To do that, he looks at the insulin dosing tools and the algorithms used within the hospital setting for insights on what future devices may hold.
The article features Monarch’s Executive Vice President and Chief Clinical Officer, Laurel Fuqua, RN, MSN, discussing EndoTool’s inpatient dosing algorithms and Ellie Strock, Vice President of US Medical Affairs at Voluntis, Monarch’s partner, discussing the outpatient movement.
Read the full article